Clinical Relevance of CD4 Cytotoxic T Cells in High-Risk Neuroblastoma

por Tang, Xao X., Shimada, Hiroyuki, Ikegaki, Naohiko
Publicado 2021

Macrophage-mediated anti-tumor immunity against high-risk neuroblastoma

por Tang, Xao X., Shimada, Hiroyuki, Ikegaki, Naohiko
Publicado 2022

S(+)-ibuprofen destabilizes MYC/MYCN and AKT, increases p53 expression, and induces unfolded protein response and favorable phenotype in neuroblastoma cell lines

por IKEGAKI, NAOHIKO, HICKS, SAKEENAH L., REGAN, PAUL L., JACOBS, JOSHUA, JUMBO, AMINA S., LEONHARDT, PAYTON, RAPPAPORT, ERIC F., TANG, XAO X.
Publicado 2013

Destabilization of MYC/MYCN by the mitochondrial inhibitors, metaiodobenzylguanidine, metformin and phenformin

por WANG, STEPHANIE S., HSIAO, RUTH, LIMPAR, MARIKO M., LOMAHAN, SARAH, TRAN, TUAN-ANH, MALONEY, NOLAN J., IKEGAKI, NAOHIKO, TANG, XAO X.
Publicado 2014

MYC-family protein overexpression and prominent nucleolar formation represent prognostic indicators and potential therapeutic targets for aggressive high-MKI neuroblastomas: a repo...

por Niemas-Teshiba, Risa, Matsuno, Ryosuke, Wang, Larry L., Tang, Xao X., Chiu, Bill, Zeki, Jasmine, Coburn, Jeannine, Ornell, Kimberly, Naranjo, Arlene, Van Ryn, Collin, London, Wendy B., Hogarty, Michael D., Gastier-Foster, Julie M., Look, A. Thomas, Park, Julie R., Maris, John M., Cohn, Susan L., Seeger, Robert C., Asgharzadeh, Shahab, Ikegaki, Naohiko, Shimada, Hiroyuki
Publicado 2017